Webinars & Whitepapers →
Serial Entrepreneur and Investor
Founder and CEO, Acme Packet
Medical College of Wisconsin director of research commercialization
Managing Partner at Pappas Ventures
VP of Research & Policy, Ewing Marion Kauffman Foundation
Partner, Third Rock Ventures
Vice President for Research at UT Health Science Center at San Antonio
March 18, 2020 · San Diego
December 5th, 2007
GlaxoSmithKline has written Lexington, MA-based Synta Pharmaceuticals (NASDAQ: SNTA) a check for $80 million. The payment is the first installment under a cancer-drug development agreement that could ultimately be worth $1.1 billion for the Lexington firm.
Rebecca is Xconomy's co-founder. Follow @
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
From Our Partners · Special Report
Advice for funding and future transformational opportunities
From Our Editors · Special Report
Key indicators & expert insight from industry leaders
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.